SELLAS Life Sciences Group, Inc. Increase (Decrease) in Prepaid Expense
SELLAS Life Sciences Group, Inc. (SLS) reported Increase (Decrease) in Prepaid Expense of $467.00 thousand for the 105-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2011-11-14
- SELLAS Life Sciences Group, Inc. increase (decrease) in prepaid expense for the quarter ending 2011-09-30 was $223.00K, a 829.17% increase year-over-year.
- SELLAS Life Sciences Group, Inc. increase (decrease) in prepaid expense for the quarter ending 2010-09-30 was $24.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 102 month | Increase (Decrease) in Prepaid Expense 105 month |
|---|---|---|---|---|---|
| 2011-09-30 | $223.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $317.00K 10-Q · filed 2011-11-14 | $467.00K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $94.00K 10-Q/A · filed 2011-10-28 | $244.00K 10-Q/A · filed 2011-10-28 | |||
| 2010-09-30 | $24.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $214.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $190.00K 10-Q/A · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |